Report cover image

Canada Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Publisher GlobalData
Published Jun 23, 2025
Length 158 Pages
SKU # GBDT20178459

Description

Canada Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Summary

GlobalData’s “Canada Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Canada Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The Canada Oncology Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the Canada Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

Canada Oncology is segmented as follows -
  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests
Reasons to Buy

The Canada Oncology Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

158 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Oncology Market, Canada
3.1 Oncology Market, Canada, Revenue ($m), 2018-2033
3.1.1 ALK Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.2 BCR-ABL Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.3 BRAF Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.4 BRCA Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.5 Colorectal Cancer Screening Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.6 EGFR Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.7 HER2 Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.1.8 KRAS Tests Market, Canada, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, Canada, Volume (Units), 2018-2033
3.2.1 ALK Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.2 BCR-ABL Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.3 BRAF Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.4 BRCA Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.5 Colorectal Cancer Screening Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.6 EGFR Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.7 HER2 Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.2.8 KRAS Tests Market, Canada, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, Canada, Average Price ($) , 2018-2033
3.4 Oncology Market, Canada, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in Canada, Oncology Market
4.1 Agilent Technologies Inc
4.1.1 Company Overview
4.2 F. Hoffmann-La Roche Ltd
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Qiagen NV
4.4.1 Company Overview
4.5 Danaher Corp
4.5.1 Company Overview
4.6 Eiken Chemical Co Ltd
4.6.1 Company Overview
4.7 Thermo Fisher Scientific Inc
4.7.1 Company Overview
4.8 Amoy Diagnostics Co Ltd
4.8.1 Company Overview
4.9 Hemosure Inc
4.9.1 Company Overview
4.10 Quidelortho Corp
4.10.1 Company Overview
5 Oncology Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Quest Diagnostics Acquires LifeLabs for USD984.2 Million
6.2 Equity Offerings
6.2.1 ProMIS Neurosciences Raises USD30.38 Million in Private Placement of Units
6.3 Venture Financing
6.3.1 Syantra Secures USD3.6 Million in Series A-1 Funding
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 04, 2025: Groundbreaking Alzheimer's and Cancer Studies Receive $7.2M Boost
7.1.2 Jan 08, 2025: Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies
7.2 Financial Announcements
7.2.1 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025
7.2.2 Dec 16, 2024: StageZero Life Sciences Reports Q3 2024 Results and Operational Update
7.2.3 Nov 28, 2024: MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
7.2.4 Oct 01, 2024: StageZero Life Sciences Announces Q2 2024 Financial Results and Operational Update
7.2.5 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
7.3 Government and Public Interest
7.3.1 Jul 13, 2024: New Analysis Examines Role of Conditional Approvals on Access to Promising Oncology Therapies
7.4 Other Significant Developments
7.4.1 Feb 27, 2025: Avitia Launches AI-Powered Platform for Rapid & Point-Of-Care Cancer Testing
7.4.2 Nov 29, 2024: Government of Canada Invests in Breast Cancer Research and Public Awareness
7.4.3 Nov 14, 2024: Brain Tumor Funders' Collaborative Announces New Grant Opportunity to Support Studies on Liquid Biopsy in Primary Brain Tumors
7.4.4 Aug 19, 2024: ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology
7.5 Product News
7.5.1 May 13, 2025: Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025
7.5.2 May 05, 2025: Ontada Illuminates the Power of its Real-World Evidence to Improve Health Outcomes for People with Cancer at ISPOR 2025
7.5.3 Mar 24, 2025: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
7.5.4 Nov 21, 2024: Bostongene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2024 Annual Meeting
7.5.5 Nov 14, 2024: New Microfluidic Device Reveals How the Shape of a Tumour Can Predict a Cancer’s Aggressiveness
7.5.6 Oct 23, 2024: Lung Health Foundation: New Evict Radon National Study Report Underscores ‘Urgent Need for Canada-Wide Advocacy’ to Reduce Dangerous Radon Levels in Canadian Homes
7.5.7 Oct 01, 2024: PocketHealth Launches New Breast Health Tools to Help Detect Breast Cancer Earlier
7.5.8 Jun 26, 2024: Scientists discover high-risk form of endometrial cancer - and how to test for it - using AI
7.5.9 Jun 12, 2024: 'Precision Medicine is Transforming Cancer Care' - Colorectal Cancer Resource & Action Network (CCRAN) Announces Second Annual Pan-Tumor Biomarkers Conference
7.6 Strategy And Business Planning
7.6.1 Nov 08, 2024: Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment
7.6.2 Oct 16, 2024: Cervical and Lung Cancer Screening Programs Expanding and Innovating Across Canada, Canadian Partnership Against Cancer's New Reports Show
7.6.3 Sep 16, 2024: New Collaboration to Introduce Liquid Biopsy Testing for Lung Cancer
7.6.4 Sep 04, 2024: Semaphore Solutions Announces Expansion of Partnership With BillionToOne
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Oncology Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, Canada, Volume (Units), 2018-2033
Table 11: ALK Tests Market, Canada, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, Canada, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, Canada, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, Canada, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, Canada, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, Canada, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, Canada, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, Canada, Volume (Units), 2018-2033
Table 19: Oncology Market, Canada, Average Price ($), 2018-2033
Table 20: Oncology Market, Canada, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Quest Diagnostics Acquires LifeLabs for USD984.2 Million
Table 23: ProMIS Neurosciences Raises USD30.38 Million in Private Placement of Units
Table 24: Syantra Secures USD3.6 Million in Series A-1 Funding
Table 25: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Oncology Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, Canada, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, Canada, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, Canada, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, Canada, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, Canada, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, Canada, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, Canada, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, Canada, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, Canada, Volume (Units), 2018-2033
Figure 19: Oncology Market, Canada, Company Share (%), 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us